Pasien diabetes melitus (DM) cenderung menujukkan percepatan proses aterosklerotik dan akibatnya risiko penyakit kardiovaskular lebih tinggi seperti penyakit jantung koroner.DM sering dipersulit dangan komorbiditas lainnya yang berkontribusi terhadap peningkatan risiko penyakit kardiovaskular (seperti, hipertensi, penyakit ginjal kronis, dan dislipidemia).  Kontrol glikemik yang tidak adekuat atau terjadinya resistensi insulin mengaktifkan saraf simpatis, yang memicu MBPS berlebihan pada pasien DM.MBPS berlebihan terlibat dalam patogenesis kejadian kardiovaskular pada pagi hari  dengan mencetuskan stres hemodinamik. Tujuan umum dari penelitian ini adalah untuk mengetahui hubungan antara  pengendalian glukosa darah dan MBPS, serta hubungan antara MBPS dan kejadian penyakit jantung koroner pada pasien diabetes melitus di Rumah Sakit Umum Cut Meutia. Penelitian ini merupakan penelitian observasional analitik dengan rancangan potong lintang (cross sectional). Sumber data dalam penelitian ini diperoleh dari data primer berdasarkan hasil identifikasi karakteristik pasien, pengukuran morning blood pressure surge, kadar gula darah puasa dan pemeriksaan EKG. Hasil penelitian menunjukkan sebesar 75% responden pada penelitian ini (n = 32) memiliki kadar gula darah puasa yang tidak terkontrol, 53,1% responden dengan morning hypertension dan 62,5% responden mengalami Penyakit Jantung Koroner (PJK).  Pada analisis bivariat, hasil menunjukkan terdapat hubungan antara kontrol gula darah puasa dengan morning hypertension (p value = 0.024%). Secara umum terdapat hubungan timbal balik antara DM dengan hipertensi.

Agranulocytosis as adversed effect of antithyroid drug (ATD) in patients with Graves disease is a rare complication but it can be serious and life threatening. The mortality rate 2-10% caused by severe infection as complications. Immediate diagnosis and management are essential for proper treatment and good prognosis. A 35-year-old female with Graves disease was complaining of fever and sore throat. She was initially treated with Thiamizole 1x20 mg for 2 weeks. Physical examination revealed leukoplakia and diffuse struma. Laboratory test : FT4 43 pmol/L, TSHs :0,005 uIu/mL, ANC <100/ul. Patient is diagnosed with ATD induced agranulocytosis. Treatment includes meropenem, fluconazole and GCSFs. The clinical and laboratory parameter improved after two weeks of treatment. Agranulocytosis in Graves’ disease patient which had ATD is a rare occurrence, with an incidence 0,2- 0,5% (66,7% had severe infection). The diagnostic criteria for agranulocytosis caused by ATD are hyperthyroid patients who are confirmed with an increase T4 and/or T3, decrease in TSH, ANC of 1500/ul before receiving ATD, ANC < 500/ul after initiation ATD and other causes of agranulocytosis have been excluded. In fact, most patients had ANC <100/ul. There are no symptom difference with agranulocytosis caused by other cause. High fever and sore throat are the most common symptom. Initial management are to identify, immediately stop the drug use, broad spectrum antibiotics and GCSFs. The hyperthyroidism will continue and alternative therapies should still be given. The best prevention is to educate patient and to examine granulocyte count frequently.